Section Arrow
ELUT.NASDAQ
- Elutia
(Financial Status)
Quotes are at least 15-min delayed:2026/11/20 17:54 EST
After Hours
Last
 0.92
+0.0199 (+2.21%)
Bid
0.9
Ask
0.96
High 0.92 
Low 0.8821 
Volume 1.12K 
Regular Hours (Closed)
Last
 0.9001
+0.0901 (+11.12%)
Day High 
0.9199 
Prev. Close
0.81 
1-M High
0.9598 
Volume 
83.58K 
Bid
0.9
Ask
0.96
Day Low
0.7908 
Open
0.7908 
1-M Low
0.7036 
Market Cap 
35.96M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.85 
20-SMA 0.83 
50-SMA 0.82 
52-W High 1.385 
52-W Low 0.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
1.16/-1.71
Enterprise Value
39.55M
Balance Sheet
Book Value Per Share
0.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
12.29M
Operating Revenue Per Share
1.09
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp41.98-1.01-2.35%18.14PE
After Hours 42.3233 +0.3433 +0.82%
PACBPacific Biosciences of California1.63-0.13-7.39%-- 
After Hours 1.65 +0.02 +1.23%
MDTMedtronic plc99.94-0.67-0.67%24.78PE
After Hours 99.52 -0.42 -0.42%
QSIQuantum-Si0.909-0.161-15.05%-- 
After Hours 0.93 +0.021 +2.31%
ABTAbbott Laboratories103-0.87-0.84%38.76PE
After Hours 103.53 +0.53 +0.51%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.